Lupin Limited (LUPIN.NS)

1.679,65 +24,90 (+1,50%) Alla chiusura: 03:30PM IST

Lupin Limited

Kalpataru Inspire
3rd Floor Off. Western Expressway Highway Santacruz (East)
Mumbai 400055
India
91 22 6640 2323
https://www.lupin.com

Settore/i: Healthcare
Settore: Drug Manufacturers - Specialty & Generic
Impiegati a tempo pieno: 20.933

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Ms. Vinita D. Gupta	CEO & Executive Director	109,2M	N/D	1968
Mr. Ramesh Swaminathan	Global CFO, CRO, Head of Corporate Affairs & Executive Director	66,86M	N/D	1966
Mr. Nilesh Deshbandhu Gupta	MD & Executive Director	49,6M	N/D	N/D
Mr. Johnny Mack Mikell	President & Global Head of Quality	N/D	N/D	N/D
Mr. Christoph Funke	Chief Technical Operations Officer	N/D	N/D	N/D
Mr. Sreeji Gopinathan	Chief Information Officer	N/D	N/D	N/D
Dr. Shahin Fesharaki	Global Chief Scientific Officer	N/D	N/D	N/D
Dr. Hemant Bakhru	Vice President of Investor Relations and M&A	N/D	N/D	N/D
Dr. Sofia Mumtaz	President of Legal and Compliance of Australia, Japan & Canada Business	N/D	N/D	N/D
Ms. Diana Amador-Toro	Senior Vice President of Global Compliance	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in INR.

Descrizione

Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) in India and internationally. It offers formulations for use in the therapeutic areas of cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastrointestinal, anti-infective, nonsteroidal anti-inflammatory drug therapy, respiratory, women's health, and anti-tuberculosis. The company is also involved in the provision of biosimilars; over-the-counter products; specialty products; and drug discovery and development programs in the therapeutic areas of oncology, immunology, and metabolic disorders, as well as bio clinical research activities. It operates through network consists of labs, LupiMitra collection centers, and pick-up points. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.

Governance aziendale

L'ISS Governance QualityScore di Lupin Limited al 1 maggio 2024 è 9. I criteri di valutazione fondamentali sono revisione: 10; Consiglio di Amministrazione: 4; diritti degli azionisti: 1; retribuzione: 8.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.